Abiomed, Inc. announced multiple commercial and product-innovation milestones during the first quarter of fiscal 2021, despite the slowdown in sales caused by the pandemic.
“Our disciplined execution in Q1 delivered one of our most productive quarters in my 16-year tenure with the company,” Abiomed...





